Literature DB >> 8033197

Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7-36amide) in individual ob/ob mouse beta-cells.

C A Cullinan1, E J Brady, R Saperstein, M D Leibowitz.   

Abstract

Depolarizing concentrations of glucose produce characteristic alterations of intracellular free Ca2+ ([Ca2+]i) in pancreatic beta-cells. The effects of the proposed incretin, glucagon-like peptide-1(7-36amide) (GLP-1a) on [Ca2+]i were determined from Fura-2 fluorescence ratio imaging of cultured ob/ob mouse pancreatic beta-cells. In control cells, [Ca2+]i is low in 3 mM glucose; increasing [glucose] to 8-12 mM results in an initial dip in [Ca2+]i followed by slow oscillating increases in [Ca2+]i. GLP-1a (0.03-10,000 pM) does not alter [Ca2+]i in 3 mM glucose, but does change the response to elevated glucose (8-12 mM). The time integral of the initial dip is reduced ([GLP-1a] 10-100 pM), and the integral of the [Ca2+]i signal is increased ([GLP-1a] > or = 1 pM). GLP-1a increases the frequency of sustained, stable plateau responses to elevated glucose, and the frequency of large, rapid spikes of increased [Ca2+]i associated with either plateaus, or oscillations. Application of a cAMP analog mimics most of the actions of GLP-1a. Activation of the GLP-1a receptor, or application of cAMP alters pancreatic beta-cell [Ca2+]i only when [glucose] is high.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033197     DOI: 10.1016/0143-4160(94)90014-0

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  11 in total

Review 1.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 2.  A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion.

Authors:  Makoto Shigeto; Chae Young Cha; Patrik Rorsman; Kohei Kaku
Journal:  J Mol Med (Berl)       Date:  2017-01-17       Impact factor: 4.599

3.  Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms.

Authors:  J Gromada; S Dissing; P Rorsman
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Anchoring of protein kinase A facilitates hormone-mediated insulin secretion.

Authors:  L B Lester; L K Langeberg; J D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Mechanism of action of glucagon-like peptide-1(7-36NH2) in isolated rat pancreatic islets and abrogation of its effects in long-term incubations.

Authors:  K A Gronau; P L Brubaker
Journal:  Endocrine       Date:  1995-11       Impact factor: 3.633

6.  cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).

Authors:  G G Holz; C A Leech; R S Heller; M Castonguay; J F Habener
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

7.  Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.

Authors:  Takashi Tsuboi; Gabriela da Silva Xavier; George G Holz; Laurence S Jouaville; Andrew P Thomas; Guy A Rutter
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

Review 8.  Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor.

Authors:  Francis S Willard; Kyle W Sloop
Journal:  Exp Diabetes Res       Date:  2012-05-14

9.  Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

Authors:  Derek J Hausenloy; Hannah J Whittington; Abigail M Wynne; Shah S Begum; Louise Theodorou; Niels Riksen; Mihaela M Mocanu; Derek M Yellon
Journal:  Cardiovasc Diabetol       Date:  2013-10-22       Impact factor: 9.951

10.  Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism.

Authors:  Nadia M Krasner; Yasuo Ido; Neil B Ruderman; Jose M Cacicedo
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.